Recent highlights

The strength of interdisciplinary collaboration

Dimitrios Kleftogiannis obtained his first open project support from the Western Norway Regional Health Authorities in 2024, starting in 2025 with the project “Assisting personalised treatment decisions in multiple sclerosis using data-driven immunological signatures.”

“Our success in securing this funding from Helse Vest (the Western Norway Regional Health Authorities) reflects the urgent need for improved patient stratification and personalised treatment approaches in MS. This project exemplifies the strength of interdisciplinary collaboration within our Centre, bringing together expertise from clinical neurology, immunology, and bioinformatics. Careful planning, the selection of well-defined cohorts, and the use of high-quality datasets from ongoing clinical trials allow us to generate new knowledge while ensuring the validation of our data-driven discoveries. The enthusiasm of our collaborators, the dedicated support from the leadership of Neuro-SysMed, and the invaluable guidance of our research advisor were key factors in making this application successful.”

Grant for the HYDRA platform

Irene Hana Flønes obtained her first large funding grant in 2024 with 20 MNOK from the Western Norway Regional Health Authorities' strategic funding scheme to establish “HYDRA – an adaptive design, multi-arm, multi-stage platform trial for PD.”

“HYDRA is a part of our Norwegian multi-arm, multi-stage initiative, with the ultimate goal of identifying treatments that can halt disease progression in those affected with PD. The awarding of funding needed to establish the HYDRA platform would not have been possible had it not been for Professor Tzoulis and the DECODE-PD research group, the Neuro-SysMed and its research advisor, and our colleagues in Neurology departments throughout Norway, who are essential to this work.”